MYC and breast carcinoma: Comparative analysis of HSPC111 and MYC mRNA expression revealed a weak positive correlation in this breast cancer cohort (r2 = 0.19, indicating that MYC contributed only about 20% of the variance in HSPC111 levels; Figure 5b).